Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 10:49 am Sale |
2025-01-10 | 13G | Interpace Biosciences, Inc. IDXG |
Douglas M. Singer | 195,742 4.440% |
-31,304 (-13.79%) |
Filing History |
| 2025-02-14 10:46 am Sale |
2024-12-31 | 13G | Interpace Biosciences, Inc. IDXG |
Douglas M. Singer | 227,046 5.150% |
-22,954 (-9.18%) |
Filing History |
| 2024-10-16 4:35 pm Purchase |
2024-10-11 | 13D | Interpace Biosciences, Inc. IDXG |
1315 Capital II L.P. | 9,405,940 68.000% |
6,239,274 (+197.03%) |
Filing History |
| 2024-10-16 4:30 pm Purchase |
2024-10-11 | 13D | Interpace Biosciences, Inc. IDXG |
Ampersand 2018 Limited Partnership | 13,861,386 76.000% |
9,194,720 (+197.03%) |
Filing History |
| 2024-02-12 5:01 pm Sale |
2023-12-31 | 13G | Interpace Biosciences, Inc. IDXG |
Douglas M. Singer | 250,000 5.780% |
-105,165 (-29.61%) |
Filing History |
| 2023-02-10 4:23 pm Purchase |
2022-12-31 | 13G | Interpace Biosciences, Inc. IDXG |
Douglas M. Singer | 355,165 8.320% |
62,165 (+21.22%) |
Filing History |
| 2022-02-10 5:14 pm Purchase |
2022-01-31 | 13G | Interpace Biosciences, Inc. IDXG |
Douglas M. Singer | 293,000 6.980% |
293,000 (New Position) |
Filing History |
| 2022-02-01 10:15 am Unchanged |
2022-01-28 | 13D | Interpace Biosciences, Inc. IDXG |
KAMIN PETER H | 781,956 18.600% |
0 (Unchanged) |
Filing History |
| 2022-01-13 08:30 am Unchanged |
2022-01-12 | 13D | Interpace Biosciences, Inc. IDXG |
KAMIN PETER H | 781,956 18.600% |
0 (Unchanged) |
Filing History |
| 2021-12-06 4:32 pm Unchanged |
2021-12-03 | 13D | Interpace Biosciences, Inc. IDXG |
KAMIN PETER H | 781,956 18.700% |
0 (Unchanged) |
Filing History |
| 2021-11-12 5:21 pm Unchanged |
2021-11-01 | 13D | Interpace Biosciences, Inc. IDXG |
1315 Capital II L.P. | 3,166,666 26.400% |
0 (Unchanged) |
Filing History |
| 2021-11-12 4:31 pm Unchanged |
2021-11-01 | 13D | Interpace Biosciences, Inc. IDXG |
Ampersand 2018 Limited Partnership | 4,666,666 38.900% |
0 (Unchanged) |
Filing History |
| 2021-05-19 5:39 pm Unchanged |
2021-05-10 | 13D | Interpace Biosciences, Inc. IDXG |
1315 Capital II L.P. | 3,166,666 26.500% |
0 (Unchanged) |
Filing History |
| 2021-05-18 5:01 pm Unchanged |
2021-05-10 | 13D | Interpace Biosciences, Inc. IDXG |
Ampersand 2018 Limited Partnership | 4,666,666 39.100% |
0 (Unchanged) |
Filing History |
| 2021-03-01 4:06 pm Purchase |
2021-02-18 | 13D | Interpace Biosciences, Inc. IDXG |
KAMIN PETER H | 781,956 19.300% |
781,956 (New Position) |
Filing History |
| 2021-02-12 5:06 pm Sale |
2020-12-31 | 13G | Interpace Biosciences, Inc. IDXG |
Stonepine Capital Management, LLC | 0 0.000% |
-277,277 (Position Closed) |
Filing History |
| 2021-01-21 4:49 pm Unchanged |
2021-01-07 | 13D | Interpace Biosciences, Inc. IDXG |
1315 Capital II L.P. | 3,166,666 26.600% |
0 (Unchanged) |
Filing History |
| 2021-01-19 4:13 pm Unchanged |
2021-01-07 | 13D | Interpace Biosciences, Inc. IDXG |
Ampersand 2018 Limited Partnership | 4,666,666 39.300% |
0 (Unchanged) |
Filing History |
| 2020-09-11 4:34 pm Purchase |
2020-09-03 | 13G | Interpace Biosciences, Inc. IDXG |
Stonepine Capital Management, LLC | 277,277 6.900% |
169,517 (+157.31%) |
Filing History |
| 2020-08-20 3:57 pm Sale |
2020-08-18 | 13D | Interpace Biosciences, Inc. IDXG |
Binsalamah Ziyad | 0 0.000% |
-300,000 (Position Closed) |
Filing History |